Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-061015
Filing Date
2008-11-04
Accepted
2008-11-04 16:45:17
Documents
1
Period of Report
2008-10-10

Document Format Files

Seq Description Document Type Size
1 v130474_ex.html 4  
1 v130474_ex.xml 4 4088
  Complete submission text file 0001144204-08-061015.txt   5869
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD, 711 EXECUTIVE BLVD., SUI NY 10989
Business Address 8452670707
WEINER BEN-ZION (Reporting) CIK: 0001444400 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51310 | Film No.: 081161368